SCHEMBL15956169

SCHEMBL15956169

C=CCOC(=O)c1ccc([N+](=O)[O-])c(OC)c1OCC=C

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
ALDH1A1 P00352 8/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
RAB9A P51151 2/20 0.37
POLB P06746 2/20 0.37
FLT3 P36888 1/20 0.35
KDM4E B2RXH2 5/20 0.34
TDP1 Q9NUW8 2/20 0.34
KMT2A Q03164 1/20 0.34
ABCB1 P08183 1/20 0.34
HTT P42858 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTR1A P08908 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15956265 0.90 KDM4E (0.38) CYP3A4ALDH1A1RAB9AKDM4EABCB1
SCHEMBL20764434 0.88 CYP3A4 (0.43) CYP3A4ALDH1A1TSHRHSD17B10RAB9A
SCHEMBL15956458 0.88 TSHR (0.40) ALDH1A1TSHRRAB9APOLBKDM4E
SCHEMBL5108230 0.85 CYP3A4 (0.54) CYP3A4ALDH1A1TSHRHSD17B10RAB9A
SCHEMBL8788034 0.84 CYP3A4 (0.55) CYP3A4ALDH1A1TSHRHSD17B10RAB9A
SCHEMBL15956197 0.80 ALDH1A1 (0.54) CYP3A4ALDH1A1TSHRHSD17B10RAB9A
SCHEMBL20764503 0.79 EP300 (0.41) CYP3A4ALDH1A1RAB9APOLBKDM4E
SCHEMBL17368427 0.78 CYP3A4 (0.50) CYP3A4ALDH1A1TSHRHSD17B10RAB9A
SCHEMBL8788296 0.78 MAPT (0.49) CYP3A4ALDH1A1RAB9AFLT3KDM4E
SCHEMBL20764500 0.78 ALDH1A1 (0.34) CYP3A4ALDH1A1RAB9APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2956437-B1 ALBICIDIN DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS UNIV BERLIN TECH (DE) 2023-05-10 EP disclosed
US-10308595-B2 Albicidin derivatives, their use and synthesis Technische Universität Berlin (DE) 2019-06-04 US disclosed
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2015-12-31 US disclosed
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2015-12-31 US disclosed
EP-2956437-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (FR) 2015-12-23 EP disclosed
WO-2014125075-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2014-08-21 WO disclosed
WO-2014125075-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS Technische Universität Berlin (DE) 2014-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308595-B2 Albicidin derivatives, their use and synthesis MB, ALB, BCAT2 CYP3A4 862/4885ALDH1A1 2409/4885TSHR 3877/4885
US-20150376120-A1 ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS MB, ALB, BCAT2 CYP3A4 862/4885ALDH1A1 2409/4885TSHR 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.